Bluejay Diagnostics Inc. Gains 46.36%
Fri, Jul 28, 2023 at 07:41 PM
Bluejay Diagnostics Inc. (BJDX:NASDAQ) soared at $7.83, representing a gain of 46.4%. On Fri, Jul 28, 2023, BJDX:NASDAQ hit a New 2-Week Intraday High of $9.71. The stock appeared on our News Catalysts scanner on Fri, Jul 21, 2023 at 07:23 AM in the 'SPLIT' category. From Fri, Jul 14, 2023, the stock recorded 30.00% Up Days and 36.36% Green Days
The stock spiked on Mon, Jul 24, 2023 at $13.98 with a volume of 8M+.
About Bluejay Diagnostics Inc. (BJDX:NASDAQ)
Bluejay Diagnostics Inc develops, manufactures and markets innovative clinical diagnostic products that improve the quality of medical diagnoses by developing Point-of-Care tests that provide...
Top 10 Gainers:
- Viveve Medical, Inc. (VIVE:NASDAQ), 118.75%
- Aurora Acquisition Corp. (AURC:NASDAQ), 113.21%
- Unique Fabricating, Inc. (UFAB:NYSEMKT), 60.19%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Reata Pharmaceuticals, Inc. (RETA:NASDAQ), 54.02%
- Bluejay Diagnostics Inc. (BJDX:NASDAQ), 46.36%
- Homology Medicines, Inc. (FIXX:NASDAQ), 41.49%
- ASP Isotopes Inc. (ASPI:NASDAQ), 34.44%
- Roku, Inc. (ROKU:NASDAQ), 31.41%
- View Inc. (VIEW:NASDAQ), 30.91%